A detailed history of Credit Suisse Ag transactions in Argenx Se stock. As of the latest transaction made, Credit Suisse Ag holds 770 shares of ARGX stock, worth $437,283. This represents 0.0% of its overall portfolio holdings.

Number of Shares
770
Previous 770 -0.0%
Holding current value
$437,283
Previous $292,000 3.77%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

SELL
$338.91 - $506.01 $16,945 - $25,300
-50 Reduced 6.1%
770 $292,000
Q3 2023

Nov 13, 2023

SELL
$369.35 - $548.43 $303,975 - $451,357
-823 Reduced 50.09%
820 $403,000
Q2 2023

Aug 11, 2023

BUY
$360.14 - $422.58 $212,842 - $249,744
591 Added 56.18%
1,643 $640,000
Q1 2023

May 10, 2023

SELL
$334.23 - $403.65 $65,843 - $79,519
-197 Reduced 15.77%
1,052 $391,000
Q4 2022

Feb 13, 2023

BUY
$342.17 - $402.31 $16,766 - $19,713
49 Added 4.08%
1,249 $473,000
Q2 2022

Aug 12, 2022

SELL
$269.58 - $378.88 $33.7 Million - $47.4 Million
-125,084 Reduced 99.05%
1,200 $455,000
Q1 2022

May 16, 2022

SELL
$254.45 - $351.06 $6.22 Million - $8.58 Million
-24,433 Reduced 16.21%
126,284 $39.8 Million
Q4 2021

Feb 14, 2022

SELL
$272.01 - $353.03 $15.8 Million - $20.5 Million
-57,978 Reduced 27.78%
150,717 $52.8 Million
Q3 2021

Nov 12, 2021

SELL
$295.0 - $350.58 $574,955 - $683,280
-1,949 Reduced 0.93%
208,695 $63 Million
Q2 2021

Aug 16, 2021

BUY
$257.11 - $319.92 $63,506 - $79,020
247 Added 0.12%
210,644 $63.4 Million
Q1 2021

May 14, 2021

BUY
$268.3 - $380.31 $31.1 Million - $44.1 Million
115,976 Added 122.83%
210,397 $57.9 Million
Q4 2020

Feb 12, 2021

SELL
$248.13 - $308.36 $22.1 Million - $27.4 Million
-88,980 Reduced 48.52%
94,421 $27.8 Million
Q3 2020

Nov 13, 2020

SELL
$215.51 - $272.51 $7.63 Million - $9.65 Million
-35,400 Reduced 16.18%
183,401 $48.1 Million
Q2 2020

Aug 12, 2020

SELL
$127.44 - $232.72 $8.93 Million - $16.3 Million
-70,035 Reduced 24.25%
218,801 $49.3 Million
Q1 2020

May 13, 2020

BUY
$108.83 - $165.23 $3.37 Million - $5.11 Million
30,956 Added 12.0%
288,836 $38 Million
Q4 2019

Feb 12, 2020

SELL
$106.59 - $164.21 $2.22 Million - $3.42 Million
-20,850 Reduced 7.48%
257,880 $41.4 Million
Q3 2019

Nov 12, 2019

BUY
$113.31 - $150.51 $2.08 Million - $2.77 Million
18,386 Added 7.06%
278,730 $31.8 Million
Q2 2019

Aug 14, 2019

BUY
$115.0 - $141.58 $11.4 Million - $14 Million
99,159 Added 61.52%
260,344 $36.9 Million
Q1 2019

May 14, 2019

BUY
$98.85 - $134.59 $15.9 Million - $21.7 Million
161,185 New
161,185 $20.1 Million
Q3 2018

Nov 13, 2018

SELL
$75.5 - $96.63 $202,113 - $258,678
-2,677 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$74.84 - $100.16 $200,346 - $268,128
2,677 New
2,677 $222,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $31.4B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.